Heatwurx Inc. (NASDAQ:PCSA) Stock Short Interest Report for October

Heatwurx Inc. (NASDAQ:PCSA – Get Free Report) saw a significant decrease in short interest in the month of October. As of October 30th, there was short interest totaling 26,138 shares, a decrease of 43.8% from the October 15th total of 46,488 shares. Approximately 1.1% of the shares of the company are short sold. Based on an average daily trading volume, of 27,704 shares, the days-to-cover ratio is currently 0.9 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Heatwurx in a research report on Thursday, October 15th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

Check Out Our Latest Stock Report on Heatwurx

Heatwurx Stock Up 0.6%

Heatwurx stock traded up $0.01 during trading on Tuesday, hitting $1.73. The stock had a trading volume of 21,334 shares, compared to its average volume of 120,657. Heatwurx has a 1 year low of $1.04 and a 1 year high of $8.88. The stock’s 50 day moving average is $1.80 and its two-hundred day moving average is $2.29. The stock has a market cap of $4.84 million, a price-to-earnings ratio of -0.41 and a beta of 1.24.

Heatwurx (NASDAQ:PCSA – Get Free Report) last released its earnings results on Friday, November 13th. The company reported ($61.58) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.00) by ($60.58).

About Heatwurx

(Get Free Report)

Heatwurx was an asphalt pavement repair technology company. It developed infrared-based equipment and repair methods intended to heat and reuse existing pavement, serving the road and pavement maintenance industry. Heatwurx is a historical company name associated with the business now identified by Nasdaq ticker PCSA. The public company operates as Processa Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious medical conditions.

See Also

Receive News & Ratings for Heatwurx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heatwurx and related companies with MarketBeat.com's FREE daily email newsletter.